| Literature DB >> 27994925 |
Nesrin Öcal1, Deniz Doğan1, Ali Fuat Çiçek2, Orhan Yücel1, Ergun Tozkoparan1.
Abstract
BACKGROUND: In recent days, synthetic cannabinoid derivatives have become life threatening for young people. Here, we want to share a case of acute eosinophilic pneumonia triggered by inhalation of synthetic cannabinoid, new side effects of which are being detected day by day. CASE REPORT: A 21-year-old male, who had no history of pulmonary diseases, was admitted to the clinic with shortness of breath. His oxygen saturation was measured as 85-86% in room air. Common irregular ground-glass opacities were observed in thorax radiology. His peripheral blood eosinophil count was 1100 cell/mm3 with a leukocyte differential of 12%. Sputum eosinophilia was also observed. The patient was diagnosed with acute eosinophilic pneumonia in terms of current clinical, radiological and laboratory findings. Rapid remission was achieved with corticosteroid therapy.Entities:
Keywords: Acute eosinophilic pneumonia; sputum eosinophilia; synthetic cannabinoid
Year: 2016 PMID: 27994925 PMCID: PMC5156457 DOI: 10.5152/balkanmedj.2016.151145
Source DB: PubMed Journal: Balkan Med J ISSN: 2146-3123 Impact factor: 2.021